Penciclovir Sodium

CHEMBL2079793 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

275.2 g/mol

LogP

—

Phase

4

A sodium salt form of penciclovir with the same therapeutic properties. This antiviral cream is applied to cold sores caused by herpes simplex virus to help them heal faster.

分子量

275.2400 g/mol

TPSA

115.00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

Nc1nc([O-])c2ncn(CCC(CO)CO)c2n1.[Na+]

InChI

InChI=1S/C10H15N5O3.Na/c11-10-13-8-7(9(18)14-10)12-5-15(8)2-1-6(3-16)4-17;/h5-6,16-17H,1-4H2,(H3,11,13,14,18);/q;+1/p-1

Molecular Formula

C10H14N5NaO3

HBD / HBA

3 / 6

回転可能結合数

5

重原子数

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A sodium salt form of penciclovir with the same therapeutic properties. This antiviral cream is applied to cold sores caused by herpes simplex virus to help them heal faster.

Yes, Penciclovir Sodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2079793. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 76964038. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Penciclovir Sodium PillFYIで

構造

クイックデータ

分子式: C10H14N5NaO3

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.